Keywords: Transgene, Beckman Coulter, Novartis, TG4010, Lung cancer, NSCLC, Companion diagnostic

Transgene in companion diagnostic deal with Beckman to select patients for TG4010

Article | 06 January 2011

French biotech firm Transgene (Euronext: TNG) yesterday signed an agreement with USA-based Beckman Coulter (NYSE: BEC), under which the latter ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Transgene

Beckman Coulter

Novartis

Go to company listing